Response to neoadjuvant chemotherapy based on pathologic complete response in very young patients with ER-positive breast cancer: a large, multicenter, observational study

Response to neoadjuvant chemotherapy based on pathologic complete response in very young patients with ER-positive breast cancer: a large, multicenter, observational study

Abstract Background In estrogen receptor (ER)-positive breast cancer (BC), young age is associated with poor prognosis. While very young patients respond better to chemotherapy, chemotherapy is less effective in ER-positive tumors than in ER-negative tumors. The authors tried to evaluate chemotherap...

Full description

Bibliographic Details
Main Authors: Joohyun Woo, Se Jeong Oh, Jeong-Yoon Song, Byung Joo Chae, Jung Eun Choi, Jeeyeon Lee, Heung Kyu Park, Korean Breast Cancer Society, Woosung Lim
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Cancer
Subjects:
Breast cancer
Young patients
Neoadjuvant chemotherapy
ER-positive
Pathologic complete response
Online Access:https://doi.org/10.1186/s12885-021-08355-w

Internet

https://doi.org/10.1186/s12885-021-08355-w

Similar Items